Video: Memorial Sloan-Kettering and IBM Watson Collaborate on
New Medical Technology  See video  Memorial Sloan-Kettering and
IBM are collaborating on the development of a powerful tool
built upon IBM Watson in order to provide medical professionals
with improved access to current and comprehensive cancer data
and practices.  Watson's capability to analyze huge volumes of
data and reduce it down to clinical decision points is
absolutely essential for [us] to improve on our ability to
deliver effective therapies,” says Memorial Sloan-Kettering
President and CEO Craig B. Thompson.